Search Results - "Schlembach, Pamela J."

Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer by Hoffman, Karen E, Voong, K Ranh, Levy, Lawrence B, Allen, Pamela K, Choi, Seungtaek, Schlembach, Pamela J, Lee, Andrew K, McGuire, Sean E, Nguyen, Quynh, Pugh, Thomas J, Frank, Steven J, Kudchadker, Rajat J, Du, Weiliang, Kuban, Deborah A

“…Hypofractionated radiotherapy delivers larger daily doses of radiation and may increase the biologically effective dose delivered to the prostate. We conducted…”
Get full text

Implementing a Real-Time Electronic Data Capture System to Improve Clinical Documentation in Radiation Oncology by Pan, Hubert Y., MD, Shaitelman, Simona F., MD, Perkins, George H., MD, Schlembach, Pamela J., MD, Woodward, Wendy A., MD, PhD, Smith, Benjamin D., MD

“…Abstract Purpose Electronic health records (EHRs) often store information as unstructured text, whereas electronic data capture (EDC) using structured fields…”
Get full text

Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial by Voong, K. Ranh, MD MPH, Lal, Lincy S., PhD, Kuban, Deborah A., MD, Pugh, Thomas J., MD, Swint, J. Michael, PhD, Godby, Joy, Choi, Seungtaek, MD, Lee, Andrew K., MD MPH, Schlembach, Pamela J., MD, Frank, Steven J., MD, McGuire, Sean E., MD PhD, Hoffman, Karen E., MD MPH

“…Abstract Purpose Moderately hypofractionated intensity modulated radiation therapy (HIMRT) for prostate cancer shortens the treatment course while providing…”
Get full text

Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation by Schlembach, P J, Buchholz, T A, Ross, M I, Kirsner, S M, Salas, G J, Strom, E A, McNeese, M D, Perkins, G H, Hunt, K K

“…To evaluate the volume of nodal irradiation associated with breast-conserving therapy, we defined the anatomic relationship of sentinel lymph nodes and…”
Get more information

Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase 2 Trial of Daily Partial Breast Irradiation by Reddy, Jay P., Lei, Xiudong, Bloom, Elizabeth S., Reed, Valerie K., Schlembach, Pamela J., Arzu, Isidora, Mayo, Lauren, Chun, Stephen G., Ahmad, Neelofur R., Stauder, Michael C., Gopal, Ramesh, Kaiser, Kels, Fang, Penny, Smith, Benjamin D.

“…Evidence supports use of partial-breast irradiation (PBI) in the management of early breast cancer, but the optimal dose-fractionation remains unsettled. We…”
Get full text

Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial by Shaitelman, Simona F, Schlembach, Pamela J, Arzu, Isidora, Ballo, Matthew, Bloom, Elizabeth S, Buchholz, Daniel, Chronowski, Gregory M, Dvorak, Tomas, Grade, Emily, Hoffman, Karen E, Kelly, Patrick, Ludwig, Michelle, Perkins, George H, Reed, Valerie, Shah, Shalin, Stauder, Michael C, Strom, Eric A, Tereffe, Welela, Woodward, Wendy A, Ensor, Joe, Baumann, Donald, Thompson, Alastair M, Amaya, Diana, Davis, Tanisha, Guerra, William, Hamblin, Lois, Hortobagyi, Gabriel, Hunt, Kelly K, Buchholz, Thomas A, Smith, Benjamin D

“…The most appropriate dose fractionation for whole-breast irradiation (WBI) remains uncertain. To assess acute and 6-month toxic effects and quality of life…”
Get more information

Outcomes After Palliative Radiotherapy in Patients with Symptomatic Locoregionally Advanced Breast Cancer by Jacomina, Luisa E., Swanson, David M., Mitchell, Melissa P., Woodward, Wendy A., Smith, Benjamin D., Hoffman, Karen E., Goodman, Chelain R., Garber, Haven R, Sun, Susie X., Yap, Timothy A., Meric-Bernstam, Funda, Arzu, Isidora Y., Bloom, Elizabeth S., Schlembach, Pamela J., Strom, Eric A., Stauder, Michael C., Shaitelman, Simona F.

“…Symptomatic locoregionally advanced breast cancer (SLABC) can cause troublesome pain or wound complications that negatively impact quality of life. Although…”
Get full text

Longitudinal analysis of patient‐reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole‐breast irradiation by Swanick, Cameron W., Lei, Xiudong, Shaitelman, Simona F., Schlembach, Pamela J., Bloom, Elizabeth S., Fingeret, Michelle C., Strom, Eric A., Tereffe, Welela, Woodward, Wendy A., Stauder, Michael C., Dvorak, Tomas, Thompson, Alastair M., Buchholz, Thomas A., Smith, Benjamin D.

“…BACKGROUND The authors compared longitudinal patient‐reported outcomes and physician‐rated cosmesis with conventionally fractionated whole‐breast irradiation…”
Get full text

Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial by Grossberg, Aaron J, Lei, Xiudong, Xu, Ting, Shaitelman, Simona F, Hoffman, Karen E, Bloom, Elizabeth S, Stauder, Michael C, Tereffe, Welela, Schlembach, Pamela J, Woodward, Wendy A, Buchholz, Thomas A, Smith, Benjamin D

“…Whether genetic factors can identify patients at risk for radiation-induced fibrosis remains unconfirmed. To assess the association between the C-509T variant…”
Get more information

Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial by Hoffman, Karen E, Skinner, Heath, Pugh, Thomas J, Voong, Khinh R, Levy, Lawrence B, Choi, Seungtaek, Frank, Steven J, Lee, Andrew K, Mahmood, Usama, McGuire, Sean E, Schlembach, Pamela J, Du, Weiliang, Johnson, Jennifer, Kudchadker, Rajat J, Kuban, Deborah A

“…Hypofractionated prostate radiotherapy may increase biologically effective dose delivered while shortening treatment duration, but information on…”
Get full text

Enhancing clinical trial enrollment at MD Anderson Cancer Center satellite community campuses by Ludmir, Ethan B, Adlakha, Erica K, Chun, Stephen G, Reed, Valerie K, Arzu, Isidora Y, Ahmad, Neelofur, Bloom, Elizabeth, Chronowski, Gregory M, Delclos, Marc E, Mayo, Lauren L, Schlembach, Pamela J, Liao, Zhongxing, Koong, Albert C, Herman, Joseph M, Shah, Shalin J

Get more information

Prospective peer review quality assurance for outpatient radiation therapy by Ballo, Matthew T., Chronowski, Gregory M., Schlembach, Pamela J., Bloom, Elizabeth S., Arzu, Isadora Y., Kuban, Deborah A.

“…We implemented a peer review program that required presentation of all nonpalliative cases to a weekly peer review conference. The purpose of this review is to…”
Get full text

A phase II clinical trial of frameless, fractionated stereotactic radiation therapy for brain metastases by Garg, Amit K, Hernandez, Mike, Schlembach, Pamela J, Bowers, John R, McAleer, Mary F, Brown, Paul D, Gopal, Ramesh, Wiederhold, Lee, Swanson, Todd, Shah, Shalin J, Li, Jing, Ferguson, Sherise D, Philip, Nancy V, DeGracia, Lilybeth, Bloom, Elizabeth S, Chun, Stephen G

“…Stereotactic radiation therapy yields high rates of local control for brain metastases, but patients in rural or suburban areas face geographic and…”
Get full text

Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy by Stecklein, Shane R., Shaitelman, Simona F., Babiera, Gildy V., Bedrosian, Isabelle, Black, Dalliah M., Ballo, Matthew T., Arzu, Isadora, Strom, Eric A., Reed, Valerie K., Dvorak, Tomas, Smith, Benjamin D., Woodward, Wendy A., Hoffman, Karen E., Schlembach, Pamela J., Kirsner, Steve M., Nelson, Christopher L., Yang, Jinzhong, Guerra, William, Dibaj, Shiva, Bloom, Elizabeth S.

“…This study aimed to prospectively characterize toxicity and cosmesis after accelerated partial breast irradiation (APBI) with 3-dimensional conformal radiation…”
Get full text

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte‐predominant Hodgkin disease by Wilder, Richard B., Schlembach, Pamela J., Jones, Dan, Chronowski, Gregory M., Ha, Chul S., Younes, Anas, Hagemeister, Fredrick B., Barista, Ibrahim, Cabanillas, Fernando, Cox, James D.

“…BACKGROUND Lymphocyte‐predominant Hodgkin disease (LPHD) is rare and has a natural history different from that of classic Hodgkin disease. There is little…”
Get full text

Radiotherapy alone for lymphocyte-predominant Hodgkin's disease by SCHLEMBACH, Pamela J, WILDER, Richard B, JONES, Dan, HA, Chul S, FAYAD, Luis E, YOUNES, Anas, HAGEMEISTER, Fredrick, HESS, Mark, CABANILLAS, Fernando, COX, James D

“…The purpose of the study was to analyze the results with radiotherapy alone in a select group of asymptomatic adults with nonbulky, early-stage…”
Get full text

Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas by Schlembach, P J, Wilder, R B, Tucker, S L, Ha, C S, Rodriguez, M A, Hess, M A, Cabanillas, F F, Cox, J D

“…To analyze the impact of involved field radiotherapy on local control, freedom from progression, and overall survival in patients with clinical Stage III-IV,…”
Get more information

Gallium scan diagnosis of sarcoidosis in the presence of equivocal radiographic and CT findings: value of lacrimal gland biopsy by Savolaine, E R, Schlembach, P J

Get more information

Comparison of Intensity Modulated Radiotherapy Versus Conventional Treatment Planning in Bilateral and Unilateral Post-Operative Thyroid Cancer: P030 by Schlembach, Pamela J., Salehpour, Mohammed, Wong, Pei-Fong, Gopal, Ramesh, Ang, K. Kian, Garden, Adam S.

Get full text

Radiotherapy Alone for Lymphocyte Predominant Hodgkins Disease: 9:07 AM (12) by Schlembach, Pamela J., Wilder, Richard B., Jones, Dan, Ha, Chul S., Fayad, Luis E., Cox, James D.

Get full text